KTTA
Pasithea Therapeutics CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$17.21M
P/E Ratio
—
EPS
$-2.91
Beta
0.25
52W High
$2.06
52W Low
$0.28
50-Day MA
$0.77
200-Day MA
$0.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Pasithea Therapeutics Corp
Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida.
Fundamentals
| Revenue (TTM) | 486,560 |
| Gross Profit (TTM) | -2,213 |
| EBITDA | $-16.03M |
| Operating Margin | 0.00% |
| Return on Equity | -58.40% |
| Return on Assets | -27.40% |
| Revenue/Share (TTM) | $0.37 |
| Book Value | $2.39 |
| Price-to-Book | 0.31 |
| Price-to-Sales (TTM) | 42.15 |
| EV/Revenue | 277.44 |
| EV/EBITDA | 2.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1498.00% |
| Shares Outstanding | $24.94M |
| Float | $10.20M |
| % Insiders | 1.49% |
| % Institutions | 75.15% |
Historical Volatility
HV 10-Day
50.69%
HV 20-Day
59.18%
HV 30-Day
55.46%
HV 60-Day
61.15%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($3.00 target)
1
BuyData last updated: 4/28/2026